Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-01-12
1980-12-16
Waltz, Thomas A.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260544N, 564153, C07C10378, A61K 2902, C07C 6324
Patent
active
042397472
ABSTRACT:
Dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) of the formula ##STR1## wherein R.sub.1 is lower straight-chain or branched-chain mono- or polyhydroxyalkyl;
REFERENCES:
patent: 2853424 (1958-09-01), Priewe et al.
patent: 3178473 (1965-04-01), Hottermann et al.
patent: 3290366 (1966-12-01), Hoey
patent: 3409662 (1968-11-01), Larsen
patent: 3557197 (1971-01-01), Felder et al.
patent: 3660464 (1972-05-01), Bernstein et al.
patent: 3701771 (1972-10-01), Almen et al.
patent: 3732293 (1973-05-01), Ackerman
patent: 3939204 (1976-02-01), Buttermann
patent: 4001298 (1977-01-01), Gries et al.
patent: 4132731 (1979-01-01), Klieger et al.
patent: 4139605 (1979-02-01), Felder et al.
Pfeiffer Heinrich
Speck Ulrich
Schering Aktiengesellschaft
Waltz Thomas A.
LandOfFree
Dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-607729